Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:1426-1431
Published online before print June 2, 2005, doi: 10.1161/01.STR.0000169934.96354.3a
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/7/1426    most recent
01.STR.0000169934.96354.3av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Guelpen, B.
Right arrow Articles by Winkvist, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Guelpen, B.
Right arrow Articles by Winkvist, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYANOCOBALAMIN
*FOLIC ACID
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Epidemiology
Right arrow Acute Cerebral Hemorrhage
Right arrow Acute Cerebral Infarction

(Stroke. 2005;36:1426.)
© 2005 American Heart Association, Inc.


Original Contributions

Folate, Vitamin B12, and Risk of Ischemic and Hemorrhagic Stroke

A Prospective, Nested Case-Referent Study of Plasma Concentrations and Dietary Intake

Bethany Van Guelpen, MSSc; Johan Hultdin, MD; Ingegerd Johansson, DDS, PhD; Birgitta Stegmayr, PhD; Göran Hallmans, MD, PhD; Torbjörn K. Nilsson, MD, PhD; Lars Weinehall, MD, PhD; Cornelia Witthöft, PhD; Richard Palmqvist, MD, PhD Anna Winkvist, PhD

From the Departments of Medical Biosciences, Pathology (B.V.G., R.P.) and Clinical Chemistry (J.H.), Odontology, Cariology (I.J.), Public Health and Clinical Medicine, Medicine (B.S.), Nutrition Research (G.H.), and Epidemiology (L.W.), Umeå University Hospital, Umeå, Sweden; Clinical Chemistry (T.K.N.), Örebro University Hospital, Örebro, Sweden; Food Science (C.W.), Swedish University of Agricultural Sciences, Uppsala, Sweden; and Clinical Nutrition (A.W.), The Sahlgrenska Academy, Göteborg University, Gothenburg, Sweden.

Correspondence to Bethany Van Guelpen, Department of Medical Biosciences, Pathology, Building 6M, 2nd Floor, Umeå University, SE-901 85 Umeå, Sweden. E-mail Bethany.Van.Guelpen{at}nutrires.umu.se

Background and Purpose— Folate metabolism has been implicated in stroke. However, the possibility of a role for folate and vitamin B12, independent of their effects on homocysteine status, remains to be explored. The aim of this prospective, nested case-referent study was to relate plasma and dietary intake levels of folate and vitamin B12 to risk of stroke, taking into consideration plasma homocysteine concentrations and methylenetetrahydrofolate reductase polymorphisms.

Methods— Subjects were 334 ischemic and 62 hemorrhagic stroke cases and matched double referents from the population-based Northern Sweden Health and Disease Cohort.

Results— Plasma folate was statistically significantly associated with risk of hemorrhagic stroke in an inverse linear manner, both in univariate analysis and after adjustment for conventional risk factors including hypertension (odds ratio [OR] for highest versus lowest quartile 0.21 (95% confidence interval [CI], 0.06 to 0.71; P for trend=0.008)). Risk estimates were attenuated by inclusion of homocysteine in the model (OR, 0.34; 95% CI, 0.08 to 1.40; P for trend=0.088). A similar pattern was observed for increasing folate intake (multivariate OR, 0.07; 95% CI, 0.01 to 0.55; P for trend=0.031 without homocysteine, and OR, 0.16, 95% CI, 0.02 to 1.23; P for trend=0.118 with homocysteine in the analysis). We found little evidence of an association between plasma or dietary folate and risk of ischemic stroke. Neither plasma nor dietary vitamin B12 was associated with risk of either stroke subtype.

Conclusions— The results of this study suggest a protective role for folate, possibly in addition to its effects on homocysteine status, in hemorrhagic but not ischemic stroke.


Key Words: cerebral infarct • intracerebral hemorrhage • folate • vitamin B12 • risk factors • Sweden




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
S. C. Larsson, S. Mannisto, M. J. Virtanen, J. Kontto, D. Albanes, and J. Virtamo
Folate, Vitamin B6, Vitamin B12, and Methionine Intakes and Risk of Stroke Subtypes in Male Smokers
Am. J. Epidemiol., April 15, 2008; 167(8): 954 - 961.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Weikert, J. Dierkes, K. Hoffmann, K. Berger, D. Drogan, K. Klipstein-Grobusch, J. Spranger, M. Mohlig, C. Luley, and H. Boeing
B Vitamin Plasma Levels and the Risk of Ischemic Stroke and Transient Ischemic Attack in a German Cohort
Stroke, November 1, 2007; 38(11): 2912 - 2918.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
L. A. Bazzano, K. Reynolds, K. N. Holder, and J. He
Effect of Folic Acid Supplementation on Risk of Cardiovascular Diseases: A Meta-analysis of Randomized Controlled Trials
JAMA, December 13, 2006; 296(22): 2720 - 2726.
[Abstract] [Full Text] [PDF]